Logo image of ED4.DE

EDAG ENGINEERING GROUP AG (ED4.DE) Stock Fundamental Analysis

FRA:ED4 - Deutsche Boerse Ag - CH0303692047 - Common Stock - Currency: EUR

5.4  +0.36 (+7.14%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to ED4. ED4 was compared to 30 industry peers in the Automobile Components industry. ED4 scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ED4 has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year ED4 has reported negative net income.
ED4 had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: ED4 reported negative net income in multiple years.
ED4 had a positive operating cash flow in each of the past 5 years.
ED4.DE Yearly Net Income VS EBIT VS OCF VS FCFED4.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

1.2 Ratios

ED4's Return On Assets of -3.12% is on the low side compared to the rest of the industry. ED4 is outperformed by 73.33% of its industry peers.
ED4 has a Return On Equity of -16.91%. This is in the lower half of the industry: ED4 underperforms 73.33% of its industry peers.
Industry RankSector Rank
ROA -3.12%
ROE -16.91%
ROIC N/A
ROA(3y)2%
ROA(5y)0.77%
ROE(3y)8.76%
ROE(5y)2.64%
ROIC(3y)N/A
ROIC(5y)N/A
ED4.DE Yearly ROA, ROE, ROICED4.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

In the last couple of years the Operating Margin of ED4 has remained more or less at the same level.
The Gross Margin of ED4 (88.49%) is better than 100.00% of its industry peers.
In the last couple of years the Gross Margin of ED4 has remained more or less at the same level.
ED4 does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 88.49%
OM growth 3Y0.14%
OM growth 5Y0.46%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.51%
GM growth 5Y1.44%
ED4.DE Yearly Profit, Operating, Gross MarginsED4.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

4

2. Health

2.1 Basic Checks

ED4 does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ED4 has about the same amount of shares outstanding.
Compared to 5 years ago, ED4 has about the same amount of shares outstanding.
The debt/assets ratio for ED4 has remained at the same level compared to a year ago.
ED4.DE Yearly Shares OutstandingED4.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
ED4.DE Yearly Total Debt VS Total AssetsED4.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

Based on the Altman-Z score of 1.54, we must say that ED4 is in the distress zone and has some risk of bankruptcy.
ED4 has a Altman-Z score (1.54) which is in line with its industry peers.
ED4 has a debt to FCF ratio of 5.62. This is a neutral value as ED4 would need 5.62 years to pay back of all of its debts.
ED4 has a better Debt to FCF ratio (5.62) than 76.67% of its industry peers.
ED4 has a Debt/Equity ratio of 2.02. This is a high value indicating a heavy dependency on external financing.
ED4's Debt to Equity ratio of 2.02 is on the low side compared to the rest of the industry. ED4 is outperformed by 76.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.02
Debt/FCF 5.62
Altman-Z 1.54
ROIC/WACCN/A
WACC3.77%
ED4.DE Yearly LT Debt VS Equity VS FCFED4.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 1.20 indicates that ED4 should not have too much problems paying its short term obligations.
ED4 has a Current ratio (1.20) which is comparable to the rest of the industry.
ED4 has a Quick Ratio of 1.18. This is a normal value and indicates that ED4 is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.18, ED4 belongs to the top of the industry, outperforming 83.33% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.2
Quick Ratio 1.18
ED4.DE Yearly Current Assets VS Current LiabilitesED4.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

3

3. Growth

3.1 Past

ED4 shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -180.14%.
ED4 shows a decrease in Revenue. In the last year, the revenue decreased by -6.39%.
The Revenue has been growing slightly by 0.98% on average over the past years.
EPS 1Y (TTM)-180.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-114.29%
Revenue 1Y (TTM)-6.39%
Revenue growth 3Y6.13%
Revenue growth 5Y0.98%
Sales Q2Q%-11.54%

3.2 Future

Based on estimates for the next years, ED4 will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.66% on average per year.
The Revenue is expected to grow by 2.55% on average over the next years.
EPS Next Y-36.81%
EPS Next 2Y7.67%
EPS Next 3Y9.66%
EPS Next 5YN/A
Revenue Next Year-4.48%
Revenue Next 2Y-1.26%
Revenue Next 3Y0.64%
Revenue Next 5Y2.55%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ED4.DE Yearly Revenue VS EstimatesED4.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 200M 400M 600M 800M 1B
ED4.DE Yearly EPS VS EstimatesED4.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 1 1.5

4

4. Valuation

4.1 Price/Earnings Ratio

ED4 reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 5.07, the valuation of ED4 can be described as very cheap.
Based on the Price/Forward Earnings ratio, ED4 is valued cheaper than 86.67% of the companies in the same industry.
ED4's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.76.
Industry RankSector Rank
PE N/A
Fwd PE 5.07
ED4.DE Price Earnings VS Forward Price EarningsED4.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ED4 is valued expensively inside the industry as 86.67% of the companies are valued cheaper.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ED4 indicates a rather cheap valuation: ED4 is cheaper than 93.33% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 2.21
EV/EBITDA 9.81
ED4.DE Per share dataED4.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y7.67%
EPS Next 3Y9.66%

0

5. Dividend

5.1 Amount

ED4 does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

EDAG ENGINEERING GROUP AG

FRA:ED4 (7/2/2025, 7:00:00 PM)

5.4

+0.36 (+7.14%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)05-08 2025-05-08
Earnings (Next)08-28 2025-08-28
Inst Owners34.59%
Inst Owner ChangeN/A
Ins Owners74.74%
Ins Owner ChangeN/A
Market Cap135.00M
Analysts48.89
Price Target8.33 (54.26%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.55
Dividend Growth(5Y)-6.05%
DP-61.3%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2%
PT rev (3m)-2%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-5.74%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.07%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 5.07
P/S 0.17
P/FCF 2.21
P/OCF 1.7
P/B 1.02
P/tB 2.6
EV/EBITDA 9.81
EPS(TTM)-0.89
EYN/A
EPS(NY)1.07
Fwd EY19.73%
FCF(TTM)2.44
FCFY45.27%
OCF(TTM)3.17
OCFY58.79%
SpS31.88
BVpS5.31
TBVpS2.07
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.12%
ROE -16.91%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 88.49%
FCFM 7.67%
ROA(3y)2%
ROA(5y)0.77%
ROE(3y)8.76%
ROE(5y)2.64%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)10.35%
ROCE(5y)8.33%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y0.14%
OM growth 5Y0.46%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.51%
GM growth 5Y1.44%
F-Score3
Asset Turnover1.11
Health
Industry RankSector Rank
Debt/Equity 2.02
Debt/FCF 5.62
Debt/EBITDA 7.95
Cap/Depr 38.67%
Cap/Sales 2.29%
Interest Coverage N/A
Cash Conversion 235.59%
Profit Quality N/A
Current Ratio 1.2
Quick Ratio 1.18
Altman-Z 1.54
F-Score3
WACC3.77%
ROIC/WACCN/A
Cap/Depr(3y)65.85%
Cap/Depr(5y)55.48%
Cap/Sales(3y)3.38%
Cap/Sales(5y)3.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-180.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-114.29%
EPS Next Y-36.81%
EPS Next 2Y7.67%
EPS Next 3Y9.66%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.39%
Revenue growth 3Y6.13%
Revenue growth 5Y0.98%
Sales Q2Q%-11.54%
Revenue Next Year-4.48%
Revenue Next 2Y-1.26%
Revenue Next 3Y0.64%
Revenue Next 5Y2.55%
EBIT growth 1Y-125.47%
EBIT growth 3Y6.27%
EBIT growth 5Y1.45%
EBIT Next Year192.09%
EBIT Next 3Y67.85%
EBIT Next 5YN/A
FCF growth 1Y1076.08%
FCF growth 3Y154.44%
FCF growth 5Y5.29%
OCF growth 1Y114.27%
OCF growth 3Y59.8%
OCF growth 5Y3.59%